Literature DB >> 18398026

Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.

Waka Ohishi1, Saeko Fujiwara, John B Cologne, Gen Suzuki, Masazumi Akahoshi, Nobuo Nishi, Ikuno Takahashi, Kazuaki Chayama.   

Abstract

BACKGROUND: Epidemiologic studies have shown effects of lifestyle-related factors on risk for hepatocellular carcinoma. However, few cohort studies have incorporated, in a strict and in-depth manner, hepatitis B virus (HBV) and hepatitis C virus (HCV) infections or investigated synergism between such factors.
METHODS: We conducted a nested case-control study using sera stored before hepatocellular carcinoma diagnosis in the longitudinal cohort of atomic bomb survivors. The study included 224 hepatocellular carcinoma cases and 644 controls that were matched to the cases on gender, age, city, time of serum storage, and method of serum storage, and countermatched on radiation dose.
RESULTS: Univariate analysis showed that HBV and HCV infections, alcohol consumption, smoking habit, body mass index (BMI), and diabetes mellitus were associated with increased hepatocellular carcinoma risk, whereas coffee drinking was associated with decreased hepatocellular carcinoma risk. Multivariate relative risks of hepatocellular carcinoma (95% confidence interval) were 45.8 (15.2-138), 101 (38.7-263), 70.7 (8.3-601), 4.36 (1.48-13.0), and 4.57 (1.85-11.3), for HBV infection alone, HCV infection alone, both HBV and HCV infections, alcohol consumption of > or =40 g of ethanol per day, and BMI of >25.0 kg/m(2) 10 years before diagnosis, respectively. HBV and HCV infection and BMI of >25.0 kg/m(2) remained independent risk factors even after adjusting for severity of liver fibrosis. Among HCV-infected individuals, the relative risk of hepatocellular carcinoma for a 1 kg/m(2) increase in BMI was 1.39 (P = 0.003).
CONCLUSIONS: To limit the risk for hepatocellular carcinoma, control of excess weight may be crucial for individuals with chronic liver disease, especially those with chronic hepatitis C.

Entities:  

Mesh:

Year:  2008        PMID: 18398026     DOI: 10.1158/1055-9965.EPI-07-2806

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.

Authors:  Shan Gao; Wan-Shui Yang; Freddie Bray; Puthiery Va; Wei Zhang; Jing Gao; Yong-Bing Xiang
Journal:  Eur J Epidemiol       Date:  2011-12-10       Impact factor: 8.082

2.  Response to Braillon.

Authors:  Te-Sheng Chang; Yu-Chih Wu; Ying-Huang Tsai; Yen-Hua Huang
Journal:  Am J Gastroenterol       Date:  2015-11       Impact factor: 10.864

3.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

Review 4.  Nonalcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Stephanie Klein; Jean-François Dufour
Journal:  Hepat Oncol       Date:  2017-10-30

Review 5.  Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Authors:  Manami Inoue; Shoichiro Tsugane
Journal:  Curr Nutr Rep       Date:  2019-09

6.  The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.

Authors:  Robert M Bigsby; Andrea Caperell-Grant
Journal:  Carcinogenesis       Date:  2011-05-23       Impact factor: 4.944

Review 7.  Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy.

Authors:  Waka Ohishi; Kazuaki Chayama
Journal:  Clin Exp Nephrol       Date:  2011-06-01       Impact factor: 2.801

Review 8.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

9.  Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus.

Authors:  Ikue Noda; Mikiya Kitamoto; Hideki Nakahara; Ryohei Hayashi; Tomoaki Okimoto; Yoshio Monzen; Hiroyasu Yamada; Masaru Imagawa; Nobuhiko Hiraga; Junko Tanaka; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-10-29       Impact factor: 7.527

Review 10.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.